Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesExenatide efficacy and safety: a systematic review
Diabetic Medicine, 09/02/09
Norris SL et al. – In subjects with poorly controlled diabetes, exenatide was associated with a reduction in HbA1c that was similar to introducing another oral agent or insulin. Weight loss may be an advantage with exenatide. Long–term studies in diverse and unselected populations are needed to clarify the benefit vs. harm profile of this drug.
Related Articles
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 88%
The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 88%
FDA Approves Revisions to Prescribing Information for Diabetes Medications
American Family Physician, 11/06/09
Relevance Score: 87%
Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting
Diabetes, Obesity and Metabolism, 10/06/09
Relevance Score: 87%
Six-month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 85%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Circulating vaspin is unrelated to insulin sensitivity in a cohort of non-diabetic humans
European Journal of Endocrinology, 12/14/09
Plasma Total Homocysteine Levels and Methylenetetrahydrofolate Reductase Gene Polymorphism in Patients with Type 2 Diabetes Mellitus
Pathophysiology of Haemostasis and Thrombosis, 12/14/09
Comparison of antihyperglycemic effects of creatine and metformin in type II diabetic patients
Clinical and Investigative Medicine, 12/14/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Thiazolidinediones and the liver in humans
Current Opinion in Lipidology, 12/14/09
Effect of Obesity on Platelet Reactivity and Response to Low-Dose Aspirin
Preventive Cardiology, 12/14/09
The role of flow-mediated dilatation in the evaluation and development of antiatherosclerotic drugs
Current Opinion in Lipidology, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor